|
|
||||||||
Division of Biologics Standards, National Institutes of Health, Bethesda, Maryland
Abstract
The measurement of neutralizing antibody response to smallpox vaccination by various test systems has been unsatisfactory because small amounts of residual, uncombined virus can multiply and obscure the result. This can be avoided by use of a tissue culture plaque technique which immobilizes the spread of residual active virus. It has been found that a successful primary vaccination elicits a uniformly good response as measured by both neutralization and hemagglutination-inhibition. In contrast, revaccination provokes a greater elevation in the neutralizing titer and this rise appears to be related to the circulating antibody level at the time of revaccination.
Footnotes
1 A portion of these data was presented at the annual meeting of the Society of American Bacteriologists, Chicago, 1958.
2 Present address: Department of Biologics Research, Chas. Pfizer & Co., Terre Haute, Indiana.
This article has been cited by other articles:
![]() |
H. M. SILBY, R. FARBER, C. J. O'CONNELL, J. ASCHER, and E. J. MARINE Acute Monarticular Arthritis After Vaccination: Report of a Case with Isolation of Vaccinia Virus from Synovial Fluid Ann Intern Med, February 1, 1965; 62(2): 347 - 350. [Abstract] [PDF] |
||||
![]() |
C. J. O'CONNELL, D. T. KARZON, A. L. BARRON, M. E. PLAUT, and V. M. ALI Progressive Vaccinia with Normal Antibodies: A Case Possibly Due to Deficient Cellular Immunity Ann Intern Med, February 1, 1964; 60(2_Part_1): 282 - 289. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |